RLS-0071

RLS-0071 · ReAlta Life Sciences, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for RLS-0071, covering 2025-05-08 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia [Phase 2]

See pricing